Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
171. |
ECCT/21/09/04 | Recombinant COVID-19 Vaccine A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of recombinant COVID-19 vaccine (Sf9 cells) for the prevention of COVID-19 in adults aged 18 years and older |
Principal Investigator(s) 1. Sylvester Kimaiyo Site(s) in Kenya 1. KAVI-Institute of Clinical Research (Nairobi City county) 2. Moi Teaching and Referral Hospital (Uasin Gishu county) 3. Kenya Medical Research Institute, Kilifi (Kilifi county) |
View |
172. |
ECCT/21/09/03 | Women TDF/FTC Benchmark Study Pharmacology of TDF-FTC Pre-exposure Prophylaxis in Kenyan Cisgender Women |
Principal Investigator(s) 1. Nelly Mugo Site(s) in Kenya KEMRI-CCR PHRD (THIKA) PROJECT |
View |
173. |
ECCT/21/09/02 | PrEDIRA - 2 Piloting HIV Pre-exposure Prophylaxis (PrEP) Integration into Services for Early Pregnancy Loss |
Principal Investigator(s) 1. Nelly Rwamba Mugo Site(s) in Kenya 1. KEMRI-CCR PHRD THIKA - Thika, Nairobi, Murang\'a, and their environs (Kiambu county) 2. Kisumu clinical trial site - Kisumu and its enrvirons (Kisumu county) 3. Mariestopes - Nairobi (Nairobi City county) |
View |
174. |
ECCT/21/09/01 | Kuwa Free! - Live free! Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives |
Principal Investigator(s) 1. Rena Patel 2. Edwin Were Site(s) in Kenya Moi Teaching and Referral Hospital |
View |
175. |
ECCT/21/08/02 | IPrEP Men\'s Study IPrEP Men’s Study: Expanding the reach of prevention for men in Kisumu, Kenya |
Principal Investigator(s) 1. Kawango Agot 2. Wafaa El-Sadr Site(s) in Kenya Kisumu Impact Research and Development Organization (K-IRDO) CRS |
View |